:max_bytes(150000):strip_icc()/GettyImages-498541178-9c2b372d25f94f1187ed43fe4c285a55.jpg?#)
Savara Reports Third Quarter 2025 Financial Results and Provides Business Update
LANGHORNE, Pa., November 12, 2025--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2025.
LANGHORNE, Pa., November 12, 2025--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2025.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
